A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project.
Vena GA, Galluccio A, De Simone C, Mastrandrea V, Buquicchio R, La Greca S, Dattola S, Puglisi Guerra A, Donato L, Cantoresi F, De Pità O, Pezza M, D Agostino M, Vernaci R, Miracapillo A, Valenti G, Cassano N.
Vena GA, et al. Among authors: mastrandrea v.
Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):227-33. doi: 10.1177/039463200902200125.
Int J Immunopathol Pharmacol. 2009.
PMID: 19309570
Free article.